In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NeuroSearch AS

www.neurosearch.com

Latest From NeuroSearch AS

Another R&D Deal For Takeda As It Inks Parkinson’s Alliance

Deals and R&D partnerships are coming thick and fast for Takeda in the first few days of the year, with the major Japanese firm unveiling a new tie-up with NsGene to progress direct-delivered cell therapies for Parkinson's disease.

BioPharmaceutical Japan

Teva In Transition: Generics, Specialty And 'The Space Between'

In an interview with Scrip's sister publication "The Pink Sheet", President of Global R&D Michael Hayden talked about integrating Allergan generics, Teva's late-stage specialty pipeline and its 17 new therapeutic entities, medicines that bridge generics and specialty medicine.

Neurology Respiratory

Teva In Transition: Generics, Specialty And ‘The Space Between’

In an interview, President of Global R&D Michael Hayden talked about integrating Allergan generics, Teva’s late-stage specialty pipeline and its 17 new therapeutic entities, medicines that bridge generics and specialty medicine.

BioPharmaceutical Clinical Trials

Invest-to-own: Biogen backs Ataxion Series A

Atlas Venture and Biogen Idec funded a $17m Series A funding round for Ataxion in an invest-to-own structure that gives Biogen an option to buy the startup company if its pan-ataxia drug candidate successfully completes a Phase I clinical trial.

Cancer Neurology
See All

Company Information

  • Industry
  • Biotechnology
  • Pharmaceuticals
  • Therapeutic Areas
  • Metabolic Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Denmark
  • Parent & Subsidiaries
  • NeuroSearch AS
  • Senior Management
  • Allan Andersen, CEO
  • Contact Info
  • NeuroSearch AS
    Phone: (45) 4460 8000
    Strandvejen 60
    Ballerup, 2900
    Denmark
Advertisement
Advertisement
UsernamePublicRestriction

Register